Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Aug 2, 2018
Tools & Techniques

Model firsts

How quantitative systems pharmacology can pick the right dose for first-in-human trials
BioCentury | Mar 11, 2016
Politics & Policy

French group outlines first-in-man trial precautions

BioCentury | Feb 1, 2016
Clinical News

BIA 10-2474: Phase I halted

BioCentury | Jan 21, 2016
Clinical News

Janssen halts trials of FAAH inhibitor

BioCentury | Jan 16, 2016
Clinical News

One volunteer brain-dead in Bial trial

Items per page:
1 - 7 of 7